FDA
approval
· 2021-10-01
FDA Approved: GABAPENTIN — Original Application (XLCare Pharmaceuticals, Inc.)
Summary
FDA approved the original ANDA for gabapentin from XLCare Pharmaceuticals, enabling a generic version of the anticonvulsant.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for GABAPENTIN (GABAPENTIN)